Premier Biomedical, Inc.
BIEI
$0.0004
-$0.0002-33.33%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Net Income | -374.40K | -- | -- | -- | -- |
| Total Depreciation and Amortization | 2.80K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 320.50K | -- | -- | -- | -- |
| Total Other Non-Cash Items | -345.00K | -- | -- | -- | -- |
| Change in Net Operating Assets | 52.10K | -- | -- | -- | -- |
| Cash from Operations | -344.10K | -- | -- | -- | -- |
| Capital Expenditure | -4.90K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.90K | -- | -- | -- | -- |
| Total Debt Issued | 333.40K | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 333.40K | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.60K | -- | -- | -- | -- |
